HK1210264A1 - 使用纖蛋白- 和/或肌聚糖γ作為指標評價脂肪團的方法和評價脂肪團有效藥物的方法 - Google Patents
使用纖蛋白- 和/或肌聚糖γ作為指標評價脂肪團的方法和評價脂肪團有效藥物的方法Info
- Publication number
- HK1210264A1 HK1210264A1 HK15110888.7A HK15110888A HK1210264A1 HK 1210264 A1 HK1210264 A1 HK 1210264A1 HK 15110888 A HK15110888 A HK 15110888A HK 1210264 A1 HK1210264 A1 HK 1210264A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cellulite
- evaluating
- fibulin
- indicator
- evaluating cellulite
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2012/073561 WO2014038097A1 (en) | 2012-09-07 | 2012-09-07 | Method of evaluating cellulite and method of evaluating cellulite-effective drug using fibulin-3 and/or sarcoglycan gamma as an indicator |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1210264A1 true HK1210264A1 (zh) | 2016-04-15 |
Family
ID=46970373
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15110888.7A HK1210264A1 (zh) | 2012-09-07 | 2015-11-04 | 使用纖蛋白- 和/或肌聚糖γ作為指標評價脂肪團的方法和評價脂肪團有效藥物的方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9933436B2 (zh) |
| EP (1) | EP2893345B1 (zh) |
| JP (1) | JP6049862B2 (zh) |
| CN (1) | CN104603616B (zh) |
| ES (1) | ES2647895T3 (zh) |
| HK (1) | HK1210264A1 (zh) |
| WO (1) | WO2014038097A1 (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ733709A (en) | 2012-01-12 | 2022-10-28 | Auxilium Int Holdings Inc | Clostridium histolyticum enzymes and methods for the use thereof |
| CN110545722B (zh) | 2017-03-01 | 2023-02-03 | 恩多风投有限公司 | 用于评估和治疗橘皮组织的装置和方法 |
| JP7227918B2 (ja) | 2017-03-28 | 2023-02-22 | エンド ベンチャーズ リミテッド | コラゲナーゼ産生の改良された方法 |
| WO2024004675A1 (ja) * | 2022-07-01 | 2024-01-04 | 国立大学法人大阪大学 | 肝臓癌の発症可能性を検査する方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3122177B2 (ja) * | 1991-08-09 | 2001-01-09 | 旭硝子株式会社 | 薄膜トランジスタとその製造方法 |
| JP3179887B2 (ja) * | 1992-09-02 | 2001-06-25 | ポーラ化成工業株式会社 | 皮膚メラニンの評価法 |
| KR20010041902A (ko) * | 1998-03-16 | 2001-05-25 | 데이비드 엠 모이어 | 포유류의 피부 내의 셀룰라이트를 감소시키는 방법 |
| ITMI991894A1 (it) | 1999-09-09 | 2001-03-09 | Carlo Ghisalberti | Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso |
| PT1603507T (pt) | 2003-03-13 | 2017-08-11 | Real Aesthetics Ltd | Tratamento da celulite por ultrassons |
| WO2006052735A2 (en) * | 2004-11-04 | 2006-05-18 | National Jewish Medical And Research Center | Fibulin-3 and uses thereof |
| ATE382327T1 (de) * | 2005-06-30 | 2008-01-15 | Evonik Goldschmidt Gmbh | Verwendung von salicyloyl-sphingoidbase zur behandlung oder verhinderung von cellilitis |
| US20070031482A1 (en) * | 2005-08-02 | 2007-02-08 | Ceramoptec Industries, Ind. | PDT treatment method for cellulites and cosmetic use |
| US20090220488A1 (en) * | 2005-08-31 | 2009-09-03 | Humphrey Gardner | Evaluating and treating scleroderma |
| WO2007100590A2 (en) * | 2006-02-22 | 2007-09-07 | Auxilium Pharmaceuticals, Inc. | Methods for treating cellulite |
| WO2008073201A2 (en) * | 2006-11-10 | 2008-06-19 | Health Research Inc. | Compositions and methods for identifying agents that alter expression of survivin |
| FR2930154B1 (fr) * | 2008-04-21 | 2012-04-20 | Oreal | Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour maintenir et/ou restaurer la tonicite et/ou la fermete de la peau |
| EP2361083A4 (en) * | 2008-10-21 | 2013-11-20 | Novodermix Internat Ltd | COMPOSITION FOR THE TREATMENT OF EPITHELIAL TISSUE |
| JP5850929B2 (ja) * | 2010-06-30 | 2016-02-03 | エイボン プロダクツ インコーポレーテッド | Ｍａｇｐ−１に刺激を与えて皮膚の外観を改善する組成物 |
-
2012
- 2012-09-07 JP JP2015510212A patent/JP6049862B2/ja active Active
- 2012-09-07 CN CN201280075648.4A patent/CN104603616B/zh active Active
- 2012-09-07 WO PCT/JP2012/073561 patent/WO2014038097A1/en active Application Filing
- 2012-09-07 US US14/426,404 patent/US9933436B2/en active Active
- 2012-09-07 EP EP12768911.5A patent/EP2893345B1/en active Active
- 2012-09-07 ES ES12768911.5T patent/ES2647895T3/es active Active
-
2015
- 2015-11-04 HK HK15110888.7A patent/HK1210264A1/zh unknown
-
2018
- 2018-02-15 US US15/897,455 patent/US10718782B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2647895T3 (es) | 2017-12-27 |
| US10718782B2 (en) | 2020-07-21 |
| CN104603616A (zh) | 2015-05-06 |
| JP2015530071A (ja) | 2015-10-15 |
| EP2893345B1 (en) | 2017-11-08 |
| WO2014038097A1 (en) | 2014-03-13 |
| US9933436B2 (en) | 2018-04-03 |
| CN104603616B (zh) | 2017-03-08 |
| EP2893345A1 (en) | 2015-07-15 |
| US20150301064A1 (en) | 2015-10-22 |
| JP6049862B2 (ja) | 2016-12-21 |
| US20180196064A1 (en) | 2018-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1209736A1 (zh) | -取代的苯甲酰胺及其使用方法 | |
| SG11201504022RA (en) | Glutamase inhibitors and method of use | |
| EP2811897A4 (en) | MEDICAL TERMINAL AND APPLICATION METHOD | |
| EP2912178A4 (en) | SUPER AMPLIFIER AND METHOD FOR USE THEREOF | |
| HK1212977A1 (zh) | 苯達莫司汀衍生物及其使用方法 | |
| EP2864004A4 (en) | DEVICE WITH ADAPTABLE DEBATMENT LENGTH, AND METHOD OF USE | |
| PL2892422T3 (pl) | Szereg elektrod i sposób mierzenia za ich pomocą | |
| LT2909204T (lt) | Gsk3 inhibitoriai ir jų panaudojimo būdai | |
| EP2928384A4 (en) | ANCHORS CAPTURED BY THE FABRIC AND METHOD OF USE | |
| EP2874647A4 (en) | METHOD FOR DIAGNOSIS AND TREATMENT | |
| HK1207968A1 (zh) | 抑制劑及其使用方法 | |
| EP2863205A4 (en) | METHOD AND DEVICE FOR EVALUATING SKIN | |
| GB2498853B (en) | Drug evaluation method and drug evaluation device | |
| IL226984A0 (en) | Device and method for measuring resistance of an object | |
| HK1222129A1 (zh) | 脱氧野尻霉素衍生物及其使用方法 | |
| HK1180858A1 (zh) | 種跨平台顯示應用的方法及裝置 | |
| EP2852397A4 (en) | HUWENTOXIN IV VARIANTS AND METHODS OF USE | |
| PL2743712T3 (pl) | Urządzenie testujące i sposób testowania | |
| EP2909606A4 (en) | DEVICE AND METHOD FOR USING THE DEVICE FOR THE DETECTION OF AMINO ACIDOPATHIES | |
| EP2988675C0 (en) | METHOD AND DEVICE FOR THE QUANTITATIVE DYNAMIC EVALUATION OF THE FUNCTIONALITY OF SKELETON MUSCLES | |
| EP2875343A4 (en) | MICROFLUIDIC NANOFLUIDIC DEVICES FOR THE DETECTION AND MEASUREMENT OF REDOX-ACTIVE SUBSTANCES | |
| EP2850895A4 (en) | METHOD AND DEVICES FOR PROVIDING AN ADDITIONAL SPECIAL PART FRAME CONFIGURATION | |
| HK1210264A1 (zh) | 使用纖蛋白- 和/或肌聚糖γ作為指標評價脂肪團的方法和評價脂肪團有效藥物的方法 | |
| GB201222626D0 (en) | Injection apparatuses and methods of calibrating injection apparatuses | |
| GB201213805D0 (en) | Alignment device and method of alignment using an alignment device |